SCHEMBL10501841

SCHEMBL10501841

S=c1c2ccccc2[se]n1-c1nccs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ MAPT P10636 4/20 0.41
▸ G6PD P11413 2/20 0.41
▸ PKM P14618 2/20 0.41
▸ MPI P34949 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ EP300 Q09472 1/20 0.41
▸ KAT2A Q92830 1/20 0.41
▸ KAT2B Q92831 1/20 0.41
▸ KMT2A Q03164 5/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ HPGD P15428 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ GLA P06280 2/20 0.35
▸ QSOX1 O00391 1/20 0.35
▸ RGS12 O14924 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5916638 0.83 METAP2 (0.54) KDM4EALDH1A1MAPTG6PDPKM
SCHEMBL10501573 0.80 MAPT (0.33) KDM4EALDH1A1MAPTG6PDPKM
SCHEMBL10501096 0.80 KDM4E (0.34) KDM4EALDH1A1MAPTG6PDPKM
SCHEMBL10502269 0.80 MAPT (0.33) KDM4EALDH1A1MAPTG6PDPKM
SCHEMBL10501085 0.80 MAPT (0.33) KDM4EALDH1A1MAPTG6PDPKM
SCHEMBL10501833 0.77 NPC1 (0.43) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL10501622 0.77 RAB9A (0.43) KDM4EALDH1A1MAPTKAT2BKMT2A
SCHEMBL10501689 0.77 FBP1 (0.35) KDM4EALDH1A1GAACYP3A4NCF1
SCHEMBL10501845 0.77 KDM4E (0.31) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL10749736 0.76 KDM4E (0.35) KDM4EALDH1A1MAPTG6PDPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback